KASEY SCHWARZ: Open Payments
NPI 1821735549 · MCHENRY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,679 in 105 payments from 16 companies in 2025. Trend: 2023 $669 · 2024 $2,088 · 2025 $2,679
Food & beverage: $2,580Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $520 |
| ABBVIE INC. | 18 | $504 |
| Madrigal Pharmaceuticals | 11 | $386 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $229 |
| Novo Nordisk Inc | 2 | $151 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $147 |
| Ardelyx, Inc. | 5 | $140 |
| Lilly USA, LLC | 5 | $109 |
| Gilead Sciences, Inc. | 3 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, SKYRIZI, RINVOQ, Wegovy, XIFAXAN, IBSRELA.
Industry payments across IL — which companies pay providers there.
